» Authors » Mariangela Pampalone

Mariangela Pampalone

Explore the profile of Mariangela Pampalone including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 13
Citations 206
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Carreca A, Tinnirello R, Miceli V, Galvano A, Gristina V, Incorvaia L, et al.
Cancers (Basel) . 2024 Jun; 16(11). PMID: 38893088
Lung cancer represents the leading cause of cancer-related mortality worldwide, with around 1.8 million deaths in 2020. For this reason, there is an enormous interest in finding early diagnostic tools...
2.
Pampalone M, Cuscino N, Iannolo G, Amico G, Ricordi C, Vitale G, et al.
Int J Mol Sci . 2024 Mar; 25(5). PMID: 38474048
Spontaneous bacterial peritonitis (SBP) is a severe complication in patients with decompensated liver cirrhosis and is commonly treated with broad spectrum antibiotics. However, the rise of antibiotic resistance requires alternative...
3.
Gallo A, Cuscino N, Contino F, Bulati M, Pampalone M, Amico G, et al.
Int J Mol Sci . 2022 Jan; 23(2). PMID: 35055049
Mesenchymal stromal/stem cells (MSCs) are believed to function in vivo as a homeostatic tool that shows therapeutic properties for tissue repair/regeneration. Conventionally, these cells are expanded in two-dimensional (2D) cultures,...
4.
Pampalone M, Vitale G, Gruttadauria S, Amico G, Iannolo G, Douradinha B, et al.
Int J Mol Sci . 2022 Jan; 23(2). PMID: 35055040
Background: Spontaneous bacterial peritonitis (SBP) is a severe and often fatal infection in patients with decompensated cirrhosis and ascites. The only cure for SBP is antibiotic therapy, but the emerging...
5.
Nigro A, Gallo A, Bulati M, Vitale G, Paini D, Pampalone M, et al.
Front Med (Lausanne) . 2021 Oct; 8:746298. PMID: 34631757
The prevalence of end-stage liver diseases has reached very high levels globally. The election treatment for affected patients is orthotopic liver transplantation, which is a very complex procedure, and due...
6.
Miceli V, Bertani A, Chinnici C, Bulati M, Pampalone M, Amico G, et al.
Int J Mol Sci . 2021 Jan; 22(2). PMID: 33419219
The clinical results of lung transplantation (LTx) are still less favorable than other solid organ transplants in both the early and long term. The fragility of the lungs limits the...
7.
Pampalone M, Corrao S, Amico G, Vitale G, Alduino R, Conaldi P, et al.
Stem Cell Rev Rep . 2021 Jan; 17(3):981-998. PMID: 33389680
Cirrhosis is associated with dysregulated immune cell activation and immune dysfunction. These conditions modify gut flora, facilitate bacterial translocation, and increase susceptibility to bacterial peritonitis and consequent systemic infections by...
8.
Pietrosi G, Fernandez-Iglesias A, Pampalone M, Ortega-Ribera M, Lozano J, Garcia-Caldero H, et al.
Liver Int . 2020 Sep; 40(10):2500-2514. PMID: 32996708
Background And Aims: Portal hypertension is the main consequence of cirrhosis, responsible for the complications defining clinical decompensation. The only cure for decompensated cirrhosis is liver transplantation, but it is...
9.
Bulati M, Miceli V, Gallo A, Amico G, Carcione C, Pampalone M, et al.
Front Immunol . 2020 Mar; 11:54. PMID: 32117234
Human mesenchymal stromal/stem cells (MSCs), being immunoprivileged and having immunomodulatory ability, represent a promising tool to be applied in the field of regenerative medicine. Based on numerous evidences, the immunological...
10.
Miceli V, Chinnici C, Bulati M, Pampalone M, Amico G, Schmelzer E, et al.
Biochem Biophys Res Commun . 2019 Nov; 522(1):171-176. PMID: 31757423
Different approaches have been studied in both preclinical and clinical settings to develop cell-based therapies and/or engineered cell-based therapies to better integrate grafts with the host. In these techniques, much...